Skip to main navigation Skip to search Skip to main content

Minimal change disease in graft versus host disease: A podocyte response to the graft?

  • Janna Huskey
  • , Chris Rivard
  • , Han Myint
  • , Scott Lucia
  • , Maxwell Smith
  • , Michiko Shimada
  • , Takuji Ishimoto
  • , Carlos Araya
  • , Eduardo H. Garin
  • , Richard J. Johnson
  • University of Colorado Anschutz Medical Campus
  • University of Colorado Denver
  • Mayo Clinic Scottsdale, AZ
  • University of Colorado School of Medicine and Children's Hospital Colorado
  • University of Florida

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Nephrotic syndrome is a rare complication of hematopoietic cell transplantation. It has been suggested that nephrotic syndrome may represent a limited form of graft-versus-host disease although the pathological link between these two entities remains unclear. In this paper, we report a case of a 61-year-old female who underwent nonmyeloablative allogenic stem cell transplantation for T-cell prolymphocytic leukemia and subsequently developed biopsy proven minimal change disease shortly after cessation of her immunosuppression therapy. Urinary CD80 was markedly elevated during active disease and disappeared following corticosteroid-induced remission. We hypothesize that alloreactive donor T cells target the kidney and induce podocyte expression of CD80 that results in proteinuria from limited 'graft versus host' disease.

Original languageEnglish
Pages (from-to)469-473
Number of pages5
JournalClinical Nephrology
Volume80
Issue number6
DOIs
StatePublished - Dec 2013
Externally publishedYes

Keywords

  • Graft versus host disease
  • Minimal change disease
  • Urinary CD80

Fingerprint

Dive into the research topics of 'Minimal change disease in graft versus host disease: A podocyte response to the graft?'. Together they form a unique fingerprint.

Cite this